This site is intended for healthcare professionals
CDK4/6 inhibitors in breast cancer

Breast cancer

Read time: 60 mins
Last updated:26th Jul 2021
Published:22nd Apr 2021

Learn to select the most suitable CDK4/6 inhibitor for your patients with breast cancer.

  • Explain to your colleague important differences between the three CDK4/6 inhibitors
  • Become an expert in navigating the treatment landscape for early and advanced breast cancer
  • Apply your knowledge to stratify and assess patients based on their risk of recurrence

Early and advanced breast cancer

 

Cancer is a leading cause of death and a burden to global life expectancy1,2

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Breast cancer risk

Women at high-risk of breast cancer (BC) are those with3,8,32:

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Breast cancer stratification

Breast carcinomas can be stratified into different entities based on clinical behaviour, histologic features, and/or by biological properties. 

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Breast cancer treatment landscape

.

Treatment of breast cancer (BC) in specialised breast units or centres, defined as specialised institutions or departments that care for a high volume of BC patients, improves disease-free survival (DFS) and overall survival (OS), daily functioning, and quality of life (QoL)3,4

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

CDK4/6 inhibitor overview

Many breast cancers are diagnosed at an early stage. 

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A BF. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;0:1–41.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: